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ABSTRACT 
It is common practice to initiate supplemental feeding in newborns if body weight 
decreases by 7-10% in the first few days after birth (7-10% rule). Standard 
hospital procedure is to initiate intravenous therapy once a woman is admitted to 
give birth. However, little is known about the relationship between intrapartum 
intravenous therapy and the amount of weight loss in the newborn. The present 
research was undertaken in order to determine what factors contribute to weight 
loss in a newborn, and to examine the relationship between the practice of 
intravenous intrapartum therapy and the extent of weight loss post-birth. Using a 
cross-sectional design with a systematic random sample of 100 mother-baby 
dyads, we examined properties of delivery that have the potential to impact 
weight loss in the newborn, including method of delivery, parity, duration of 
labour, volume of intravenous therapy, feeding method, and birth attendant. This 
study indicated that the volume of intravenous therapy and method of delivery 
are significant predictors of weight loss in the newborn (R2=15.5, p<0.01). ROC 
curve analysis identified an intravenous volume cut-point of 1225 ml that would 
elicit a high measure of sensitivity (91.3%), and demonstrated significant Kappa 
agreement (p<0.01) with excess newborn weight loss. It was concluded that 
infusion of intravenous therapy and natural birth delivery are discriminant factors 
that influence excess weight loss in newborn infants. Acknowledgement of these 
factors should be considered in clinical practice. 
v 
a 
ANOVA 
GERD 
GTPAL 
IV 
OB/GYN 
PCOS 
PIH 
LIST OF ABBREVIATIONS 
Alpha 
Analysis of variance 
Gastroesophageal reflux disease 
Gravida - number of times pregnant 
Term - number of babies carried to term (37+ weeks) 
Premature - number of babies delivered prior to 37 weeks 
Abortion - number of spontaneous or planned abortuses 
Live - number of live infants 
Intravenous 
Obstetrician and gynecologist 
Polycystic ovarian syndrome 
Pregnancy induced hypertension 
ROC curve Receiver operator characteristic curve 
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DEFINITIONS 
Cohen's Kappa analysis 
A measure of agreement for categorical data. 
Gravida 
The number of the pregnancy that a woman IS In; "in her third pregnancy a 
woman is said to be gravida three" or the total number of times a women has 
been pregnant during her lifetime. 
Intrapartum 
The time from the onset of true labor until the delivery of the infant and placenta. 
Oxytocin 
Medication used to induce and or enhance labour. 
Prevalence 
The number of people with a specific condition in a given population. 
Primiparity (primip, primiparous) 
First time infant delivery. 
ROC curve analysis 
A graphic means for assessing the ability of a screening test to discriminate 
between healthy and diseased persons. 
Sensitivity 
A measure of the usefulness of a classification scheme. Sensitivity is the 
probability that a "positive" case is correctly classified, and is plotted on the y-
axis in an ROC curve. 1-sensitivity is the false negative rate. 
Specificity 
A measure of the usefulness of a classification scheme. Specificity is the 
probability that a "negative" case is correctly classified. 1-specificity is the false 
positive rate, and is plotted on the x-axis in an ROC curve. 
VII 
CHAPTER 1- INTRODUCTION 
1.1 Preamble 
Infants are given breast milk substitutes in the hospital shortly following birth for 
various reasons, including significant dehydration, hypoglycemia, maternal illness, 
medications that are contraindicated in breastfeeding, congenital deformation of 
the infant, delayed lactogenesis, hyperbilirubinemia, or if they have lost greater 
that 7-10 percent of their body weight since birth (Alder, Williams, Anderson, 
Forsyth, Florey and Van der Velde, 2004.; Bruce and Griffioen, 1995; Hamilton 
Health Sciences, 2005; ILCA, 2005; S. Coulas personal communication, 2005). 
While in some cases, supplementation is necessary, the practice of 
supplementation based on weight loss alone, with no other criteria, can result in 
undermining the mother's confidence in her ability to breastfeed. While the '7-10 
percent weight loss rule" has long been in place, it was instituted when there 
were fewer interventions in the hospital pertaining to childbirth. Although national 
guidelines have been written based on this "rule of thumb", there is, in fact, little 
scientific evidence to support the widespread use of this protocol. 
Weight loss in the newborn is a normal physiologic process, as the 
neonate adjusts to life outside the womb. The evidence suggests that the body 
composition of the newborn changes significantly in the first few days of life as 
total body water and total body solids are lost (Rodriguez, Ventura, Samper, 
Morreno, Sarria and Perez-Gonzalez, 2000).). Since there is very little evidence 
examining the composition of the weight loss in the newborn, further studies 
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need to be undertaken to determine the various factors that influence both body 
weight at birth and body weight losses shortly after birth. 
Previous evidence indicates positive correlations between the method of 
delivery and the incidence of weight loss in newborns. Infants born by urgent 
caesarian section tend to lose a greater amount of weight than those born by 
spontaneous vaginal delivery. Correlations exist between medications given 
during labour and the amount of weight lost. However, to date there has been no 
evidence that specifically looks at the role of intravenous therapy during labour 
and newborn weight loss. 
1.2 Objectives 
The primary objective of this study was to examine the role of intrapartum 
intravenous therapy and the method of delivery on newborn weight loss. A 
secondary objective was to establish a positivity criterion of intravenous volume 
as a discriminant measure for predicting excess weight loss in newborn infants. 
1.3 Hypothesis 
It is hypothesized that the method of delivery and intravenous therapy will 
influence newborn weight loss. 
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CHAPTER 2 - REVIEW OF LITERATURE 
2.1 Introduction 
A review of the literature was conducted to determine the existing evidence with 
respect to newborn weight loss in the first week postpartum, early 
supplementation, and the duration of breastfeeding; newborn weight loss and 
use of intravenous therapy and/or medications during labour and delivery; as well 
as compositional changes in newborns in the first few days of life. 
The search involved electronic as well as hand searching peer reviewed 
journals. Databases including CINAHL and OVID were searched using keywords, 
such as labour, birth weight, weight loss, newborn weight loss, neonatal weight 
loss, newborn/neonatal body weight/composition, newborn supplementation, 
supplementing newborns, intravenous therapy, intravenous therapy newborn! 
neonatal hypernatremia, delayed lactation (lactogenesis). It was expected that all 
evidence would have been reported within the past 10 years; however, several 
articles of importance would have been excluded using this strategy, and 
therefore, the search was expanded to include any relevant article regardless of 
age. In doing so, it became clear that there are significant gaps in the literature in 
this area, and that there is a need for more current research with respect to this 
topic as some of the existing evidence is quite dated. 
2.2 Weight Loss in Newborn Infants 
Several studies have shown variances in reported weight loss. DeMarzo, Seacat 
and Neifert (1991) reported a weight loss of up to 14.3% by day 5, and that the 
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weight loss exceeded 7% in 9% of the infants they studied. Manganaro, Mami, 
Marrone, Marseglia and Gemelli (2001) reported that 8% of breastfed infants lost 
an amount equal to, or greater than, 10% of their initial birth weight, with the 
maximal weight loss occurring by day 3-4 post-birth. Dewey, Nommsen-Rivers, 
Heinig and Cohen (2003) defined excess weight loss as a decrease equal to or 
greater than 10% of birth weight by day 3; they found that 12% of breastfeeding 
infants had excessive weight loss, and that 52.6% of the infants lost over 5% of 
their birth weight. Interestingly, two studies based in the United Kingdom showed 
significantly less weight loss than those in North America. Wright and Parkinson 
(2004) stated that average weight loss was 4-7% of birth weight, but 
acknowledged that there is limited normative data on neonatal weight loss. 
MacDonald, Ross, Grant and Young (2003) completed a large study of 937 
infants, including a" methods of delivery, and both breast fed and formula fed 
infants. Infants were weighed at birth and again before discharge at 48 hours. 
They concluded that the median weight loss for all infants was 5.9%. In a 
personal communication with Dr. MacDonald, it was asked whether it is standard 
practice in the United Kingdom, to initiate intravenous therapy when a woman is 
admitted to deliver, and if not, under which circumstances would intravenous 
therapy be given.· His response was that intravenous therapy is given during 
operative deliveries, it is rarely used in routine vaginal deliveries, and it is used 
only sparingly in inductions and augmentations of labour (P. MacDonald, 
personal communication, 2006). These two reports further support the 
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hypothesis that intravenous therapy may indeed be associated with higher levels 
of weight loss in the newborn following birth. 
Previous research has shown that one circumstance under which 
intravenous therapy is given is correlated with weight loss in the newborn, 
namely caesarean section. Manganaro, Mami, Marrone, Marseglia and Gemelli 
(2001) found that 77% of infants born by caesarean section had a weight loss of 
equal to, or greater than, 10% of their birth weight. Kulski, Smith and Hartmann 
(1981) also found similar results. Further supporting these reports are the data 
from Dewey, Nommsen-Rivers, Heinig and Cohen (2003) in which it was found 
that 29% of infants born by urgent caesarean section had excessive weight loss 
(defined as >10% weight loss), and that 25% born by scheduled caesarean 
section also had excessive weight loss; on the other hand, only 11 % of assisted 
vaginal births and 10% of spontaneous vaginal births showed excessive weight 
losses. Dewey, Nommsen-Rivers, Heinig and Cohen (2003) also collected data 
on labour medications, and found that if no pain management was received, 8% 
of infants had excessive weight loss, whereas if regional anaesthesia was given 
along with intravenous medication, 26% of infants had excessive weight loss. 
They found that the correlation between labour medications and excess weight 
loss existed after controlling for confounders. Dewey, Nommsen-Rivers, Heinig 
and Cohen (2003), in the same study, also concluded that there was a 2.4 fold 
greater risk of excess weight loss in mothers with a labour longer than 14 hours, 
and that a significant correlation exists between weight loss and primiparity. 
Dewey, Nommsen-Rivers, Heinig and Cohen (2003) suggested the following 
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reasoning for this finding - the longer labour often incurred by primiparous 
women put them at greater risk of having interventions, such as oxytocin, 
epidural anaesthesia, or caesarean sections. These studies again suggest a 
relationship between the interventions routinely utilized during labour and 
delivery and infant weight loss. 
2.3 Weight Loss and Supplementation 
The significance of weight loss in a new born is important due to the fact that 
weight loss is an indicator for supplementation. Often included in many hospital 
protocols and discharge criteria, and in fact, written in the National Guidelines for 
when supplementation should be offered, is the so-called 2::7% weight loss rule. 
However, no evidence has been found to substantiate the rule. If we are to be 
giving care dependent on evidence-based practice, then any protocol used as 
common practice needs to be based on research evidence that is both current 
and comprehensive. 
Few studies have examined the relationship between newborn weight loss 
and intravenous therapy. Dahlenburg, Burnell and Braybrook (1980) looked 
specifically at the infusion of 5% Dextrose to labouring women; they found that 
infants whose mothers received the intravenous therapy lost 6.17% in the first 48 
hours, compared to 4.07% in the group who received no intravenous therapy. 
Battaglia, Prystowsky, Smison and Hellegers (1960) (reported in Dahlenburg, 
Burnell and Braybrook, 1980) reported that the infusion of 5% dextrose 
decreased the serum sodium levels of the mother, which as a result of the forces 
of osmotic pressure, led to a fluid shift to the fetus, which in turn resulted in a 
13 
subsequent increase in the baby's body weight and a lowering of the serum 
sodium levels. These results support the notion that a greater weight loss may be 
the result of the mother receiving intravenous therapy. 
2.4 Changes in birth weight and water loss in newborn infants 
Few studies have examined the time course and compositional changes that 
comprise the weight loss in the newborn infant. Rodriguez, Venture, Sam per, 
Moreno, Saria and Perez-Gonzalez (2000) used bioelectrical impedance to 
determine the changes in body composition of 43 newborns during the first 3 
days of life. Body weight was measured on the first, second, and third day of life, 
at the same time each day; the results indicated that body weight, total body 
water, and total body solids progressively decreased during that time period. 
Although this study confirmed that there is a significant total body water loss in 
the first 3 days of life, the researchers did not look at any specific variable to see 
its impact on these changes. Therefore, further research should be undertaken to 
determine those factors that influence infant body weight at birth and the losses 
in body weight that occur shortly after birth. 
2.5 Hypernatremia and body weight loss in newborns 
Laing and Wong (2002) were interested in the increasing incidence of hyper-
natremia in newborns. Through their work, it was found that plasma sodium 
concentrations in infants were raised as a result of the loss of extracellular fluid, 
and that the loss of the extracellular fluid was associated with a decreased fluid 
intake and an excessive fluid loss. There was also indication that hypernatremia 
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was more common in the infants of primiparous women (Laing and Wong, 2002; 
Moritz, Manole, Bogen and Ayus, 2005). Manganaro, Mami, Marrone, Marseglia 
and Gemelli (2001) noted similar frequencies of hypernatremia in newborns, and 
reported a higher incidence of caesarean section in those infants with hyper-
natremia. MacDonald, Ross, Grant and Young (2003) determined through their 
research that mild hypernatremia (146-150 mmolll) was found throughout all 
levels of weight loss, but that there was a significant correlation with excess weight 
loss. Based on the literature, further research is required to determine potential 
reasons for excessive fluid losses in order to prevent hypernatremia in newborns. 
2.6 Delivery, medication and weight loss in newborn infants 
Several studies have pointed out the fact that very little research has been 
completed regarding weight loss in newborns (Dewey, Nommsen-Rivers, Heinig 
and Cohen, 2003, Wright and Parkinson, 2004). Wright and Parkinson cited quite 
eloquently that "postnatal weight loss is a well known but little studied 
phenomenon" (p.255). While previous studies have reported that caesarean 
section delivery is associated with excess newborn weight loss, there have not 
been any recent studies that looked specifically at the use of intravenous therapy 
during labour and delivery for all types of deliveries. 
2.7 Summary 
The results of this literature review strongly indicate that the proposed research is 
needed if we are to clarify some of the issues regarding the incidence of newborn 
weight loss. 
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In this study, it is hypothesized that the use of intravenous therapy during 
labour increases the hydration status of the newborn as a result of a fluid shift 
from the mother to the infant, and that this fluid shift results in a higher registered 
birth weight for the infant. The infant then proceeds to progressively lose total 
body water as previous studies have shown, which also puts the infants at an 
increased risk for hypernatremia. Further, the loss of the excess fluid inflates the 
total percentage of body weight lost, and as a result, there is an increased 
chance that the infant may be subsequently supplemented with formula, which as 
the evidence suggests, can lead to shortened breastfeeding durations. 
This research could make significant contributions by providing evidence-
based information related to the administration of intravenous fluids during the 
intrapartum period. Future research should aim to examine the potential cost 
savings to hospitals from changes in hospital protocols, such as the "7-10% rule", 
limiting the administration of intravenous therapy, and the subsequent reduction 
in the number of re-admission for excessive weight losses and hypernatremic 
dehydration in newborns. 
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CHAPTER 3 - METHODS 
3.1 Design and sample 
To address our study objectives, we employed a cross sectional design in which 
137 mother/baby charts were initially examined for exclusions. Criteria for 
exclusion included multiple births, delivery complications in the mother or the 
infant, intravenous insertion in the infant, admission to neonatal intensive care, 
nasogastic feeds, malformations in the infant such as cleft lip or palate, or 
prematurity of less than 36 weeks. A final sample of 100 mother/baby dyads, 
delivered at Hamilton Health Sciences, McMaster University Medical Centre site 
in Hamilton, Ontario Canada, were systematically examined to develop a 
database for secondary analysis. 
3.2 Data collection 
An evaluation tool (Appendix 1) was designed to include various factors that 
previous studies have shown to have a potential to influence weight loss in the 
newborn. In the preparation of the data collection and evaluation tool, specialists 
in the field were consulted for advice on additional factors identified as being 
possible confounders. In the end, the data collection and evaluation tool 
consisted of 90 items of data and information. 
In addressing confidentiality, the 10 number of the infant's chart was used 
as an identifier. Once data was collected electronically and entered into the 
database, all identifying factors were removed from the data collection tools, and 
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the completed tools were stored in a combination locked safe in the researcher's 
home. The study has received approval from both the Hamilton Health Sciences -
McMaster University Research Ethics Board (Appendix 2) and the Brock 
University Research Ethics Board (Appendix 3). 
3.3 Statistical analyses 
All statistical analyses were performed using SPSS (version 16). Descriptive 
statistics and a one-way analysis of variance were calculated for parametric 
measures, including gravida, labour duration, intravenous volume and duration, 
birth weight, absolute and relative weight loss. Chi-square analysis determined 
significant differences among non-parametric measures, including newborn 
gender, delivery method, delivery attendant, and choice of epidural, induction 
and/or intravenous therapy. 
In order to examine the primary objective of the study, we used a stepwise 
multiple linear regression analysis. Three regression models were tested (Figure 
3.1). We examined the explained variance of intrapartum intravenous therapy on 
newborn weight loss (Model 1). This relationship was explored further via the 
addition of method of delivery in Model 2. Both models were adjusted for gender. 
Model 3 considered whether the effect of intrapartum intravenous therapy and 
method of delivery as predictors of newborn weight loss were different for boys 
and girls. All models were tested for multi-collinearity (variance inflation factor 
>10). 
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We utilized a receiver-operator characteristic (ROC) curve analysis to 
establish a positivity criterion (cut-point) for intravenous volume during 
intrapartum in predicting excess newborn weight loss. Cohen's Kappa analysis 
was used to evaluate the statistical accuracy of an intravenous volume with high 
sensitivity and low specificity in predicting excess newborn weight loss. The level 
of significance was set at a=0.05 for all analytic analysis. 
Model 1 
Model 2 
Model 3 
Figure 3.1 Illustration of the regression models 
19 
CHAPTER 4 - RESULTS 
4.1 Sample characteristics 
This cross sectional design incorporated secondary data analysis 
examining the role of intrapartum intravenous therapy and method of delivery on 
newborn weight loss in an attempt to examine the so-called "7-10% rule". A 
systematic random sample of 100 newborns, including 53 males and 47 females 
served as the subject base for this study. Multiple birth infants, and those with 
significant complications during, or following, intrapartum, were excluded. The 
prevalence of excessive newborn weight loss (:=::7% relative body weight) within 
the first 72 hours postpartum was 46%. 
We categorized relative weight loss in our sample to examine differences 
in delivery characteristics (Table 4.1). A Chi-square analysis was used to identify 
significant differences between weight loss groups and delivery method (p<0.01), 
epidural use (p<0.01), and intravenous use (p<0.05). There was a greater 
number of vaginal deliveries for newborns that exhibited a weight loss <7%, while 
more caesarean sections (emergency and planned) were performed in the 
delivery of newborns with weight loss :=::7%. Further, a disproportionate number of 
mothers that did not receive an epidural or intrapartum intravenous therapy, 
delivered newborns with a weight loss of :=::7% (note: this cell had a count less 
than the expected count of 5). Newborn gender, labour induction, delivery 
attendant, and feeding method were not significantly different between weight 
loss groups (p>0.05). 
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Table 4.1 Intrapartum descriptives by newborn weight loss 
Delivery method t 
Induction 
Intravenous 
therapy* 
Vaginal 
Assisted vaginal 
Emergency C-section 
Planned C-section 
Yes 
No 
Yes 
No 
42 (77.8%) 
2 ( 3.7%)a 
5 ( 9.3%) 
5 ( 9.3%) 
19 (35/2%) 
35 (64.8%) 
44 (81.5%) 
10 (18.5%) 
* = significantly different (p<O_05) between weight loss <7% and .:::7%_ 
t = significantly different (p<O_01) between weight loss <7% and .:::7%_ 
a = cell has expected count less than 5_ 
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22 (47.8%) 
1 ( 2.2%)a 
14 (30.4%) 
9 (19.6%) 
18 (39.1%) 
28 (60.8%) 
44 (95.7%) 
2 ( 4.3%)a 
4.2 Newborn delivery characteristics 
Table 4.2 presents the newborn delivery characteristics by weight loss and for 
the entire sample. Analysis of variance found significantly less intravenous 
infusion volume in the mothers of newborns with <7% weight loss (p<O.01). 
However, no significant difference was found in the duration of intravenous 
therapy between newborn weight loss groups (a trend (p=O.06) was observed). 
While the initial birth weight was comparable in both newborn groups (p>O.05), 
the absolute and relative weight losses were significantly different between the 
two groups (p<O.01). Similarly, the duration of labour and gravida (number of 
pregnancies) were not significantly different between groups. 
Table 4.2 Newborn delivery characteristics by weight loss (mean ± sd) 
t = significantly different (p<O.01) between weight loss <7% and :::7%. 
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4.3 Explaining newborn weight loss 
Table 4.3 reports the results of the regression analysis. We chose newborn 
weight loss, with a cut-off of 7% as our dependent variable. In Model 1, the main 
effect of intrapartum intravenous therapy on newborn weight loss was significant 
after adjusting for gender, and was found to explain 8.6% of newborn weight 
loss. Once method of delivery was entered in Model 2, the explained variance 
increased significantly (p<0.01), with the two variables accounting for 15.5% of 
the variance in newborn weight loss. 
In Model 3, we examined whether the effect of intrapartum intravenous 
therapy and method of delivery in predicting newborn weight loss is different for 
male and female infants. The results indicate no significant differences by 
gender, although intrapartum intravenous therapy and method of delivery 
remained significant in this model (Table 4.3). 
Table 4.3 Multiple linear regression predicting newborn weight loss 
Variables Model 1 Model 2 Model 3 
IV therapy 0.000** (0.000) 8.148E-5* (0.000) 0.9893E-5* (0.000) 
Gender 0.126 (0.098) 0.132 (0.095) 0.292 (0.192) 
Delivery method 0.114** (0.041) 0.139* (0.058) 
Gender * IV therapy -5.284E-5 (0.000) 
Gender * Delivery method -0.059 (0.083) 
Constant 0.200 0.140 0.085 
R-squared 0.086 0.155 0.165 
Unstandardized b-coefficients are reported with standard errors in parentheses. 
*p<O.05; **p<O.01 
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4.4 Establishing positivity criteria for establishing intravenous volume 
during intrapartum 
Receiver-operator characteristic (ROC) curve techniques were adopted to 
establish a positivity criterion for intravenous therapy during intrapartum. In this 
instance, a ROC curve provides a graphic means of assessing the ability of 
intravenous therapy to predict those at risk of excess newborn weight loss. The 
larger the area under the ROC curve, the more potent the discriminant ability of 
intravenous therapy, as this represents accurately identified cases (excess 
weight loss). The ROC curve for intrapartum intravenous volume, which 
illustrates the trade-off between sensitivity and specificity in determining the 
positivity criterion, is presented in Figure 4.1. The area under the curve (65%, 
with a CI of 54-76%) was significantly effective in identifying a condition of 
excess newborn weight loss (p<O.01). We chose to conservatively identify an 
intravenous volume cut-point of 1225 ml, which yielded a high measure of 
sensitivity (91.3%), while the specificity or the ability to identify those infants not 
at risk of excess weight loss was 33.3% (see Appendix 4). Cohen's Kappa 
analysis was used to evaluate the statistical accuracy of an intravenous volume 
of 1225 ml as an appropriate cut-point in predicting excess newborn weight loss. 
This cut-point demonstrated significant Kappa agreement (p<O.01) with excess 
newborn weight loss. 
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1 - Specificity 
Figure 4.1 Intrapartum intravenous volume ROC curve 
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CHAPTER 5 - DISCUSSION 
5.1 Introduction 
Newborn weight loss is a phenomena of which little is known. Based on a survey 
of available literature, it was determined that further research was warranted in 
order to support commonly used clinical practices and procedures that have 
been based on newborn weight loss. Early supplementation is one such practice 
that is undertaken when the weight loss of a new born infant is ~7% of their birth 
weight (the so-called 7-10% rule). Therefore, it is important to have a thorough 
understanding of what factor(s) contribute to the weight loss in the newborn, and 
to gain a better understanding of those factors that might result in "excessive" 
weight loss. While previous studies have examined several factors/issues and 
various strategies as part of intrapartum intervention, there is a lack of evidence 
specifically examining the role of intravenous therapy in newborn weight loss. 
The current study found that nearly one-half (46%) of the infants in the 
present study had a weight loss ~7% of their birth weight. This prevalence was 
higher than that reported in European studies (MacDonald, Ross, Grant and 
Young, 2003; Wright and Parkinson, 2004; Rodriguez, Ventura, Samper, 
Morreno, Sarria and Perez-Gonzalez, 2000). It is interesting to note that if the 
weight loss cut-off had been set to 5% instead of 7% as has been reported in 
several previous studies, then 74% of the infants in our study would have been 
classified as having had excess weight loss compared to 52.6% in other studies 
(Dewey, Nommsen-Rivers, Heinig and Cohen, 2003). Discussion with a 
researcher in the United Kingdom revealed that intravenous therapy is not 
26 
routinely used for vaginal deliveries, and is used only sparingly in operative 
deliveries (personal communication, P. MacDonald, 2006). 
5.2 Predicting excess newborn weight loss 
We determined that both the volume of intravenous therapy and the method of 
delivery are significant predictors of weight loss in a newborn. The overwhelming 
majority of pregnant women admitted to hospital received intravenous therapy 
prior to delivery. Intravenous therapy was received by 81.5% of women whose 
infants had a <7% weight loss, and by 95.7% of women whose infants had a ~7% 
weight loss. Specifically, mothers of infants that lost ~7% body weight received 
significantly more intravenously-infused normal saline fluid compared to mothers 
of infants with a weight loss of <7%. In addition, the volume infused was 
significantly correlated with an infant's post-birth weight loss. These findings 
suggest the greater volume of intravenous therapy infused to the mother 
increases the potential for the newborn infant to lose excess weight following 
delivery as a result of a fluid shift from the mother to the infant during the 
intrapartum period. While there was no significant difference in the duration of the 
intravenous infusion, the observed "trend" (p=0.06) suggests that intravenous 
therapy flow rate, and the duration of intravenous therapy, warrants further 
examination. 
Further examination of the data using a receiver-operator characteristic 
(ROC) curve analysis enabled us to determine those infants at risk for excessive 
weight loss. The area under the curve was significant, indicating that intravenous 
therapy exhibited discriminatory utility in predicting excess newborn weight loss. 
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Specifically, we found that an intravenous volume ~1225 ml infused into the 
mother prior to delivery increases the probability of a ~ 7% infant body weight loss 
within the first 3 days post-delivery by 91%. To our knowledge, there has been 
no previous literature that identifies the "critical" volume of intravenous therapy 
that would predict the probability for excess weight loss in a newborn infant. The 
high probability of excess weight loss in the infants of mothers that receive at 
least 1225 ml of saline might suggest that the birth weight of these children is 
artificially inflated. This result has significant implications for clinical practice. To 
prevent weight losses in excess of 7%, clinicians should plan carefully the use of 
intravenous therapy. If we are unable to limit the amount of intrapartum 
intravenous therapy to a level below the cut-point, clinicians should expect that 
an infant's weight loss may very well exceed 7%, and should take this into 
account when looking at supplementation. 
Current clinical practice guidelines and discharge criteria suggest 
supplementation with formula for exclusively breastfed infants who exhibit an 
excess weight loss (Health Canada, 2000; Hamilton Health Sciences, 2005). If 
this practice was adjusted, there may well be significant benefits for the mother, 
baby, and the hospital. If the infant is not supplemented, the mother's confidence 
in her ability to successfully breastfeed is increased, which has in turn been 
previously shown to increase breastfeeding durations (Alder, Williams, Anderson, 
Forsyth, Florey and Van der Velde, 2004; Bruce and Griffioen, 1995; Chezem, 
Friesen and Boettcher, 2003; Cloherty, Alexander and Holloway, 2004). In 
addition, if the weight loss is limited to <7% body weight, then there will be less 
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risk of the infant developing hypernatremic dehydration and sub-optimal 
breastfeeding behaviors (Laing and Wong, 2002). Lastly, based on the results 
presented here, if the amount of intravenous therapy infused is limited to lesser 
amounts, the infants would be expected to lose less body weight, which in turn 
would positively impact hospital budgets in that less intravenous fluid will be 
used, less formula will be used as infants will not be supplemented on account of 
excess weight loss, fewer lab tests will be run, and there would be a reduction in 
the re-admission rate for infants with excess weight loss. Looking at the "bottom 
line", in these days of tight fiscal budgets for hospitals, this research could 
indicate some future direction for further cost savings analysis. 
Our study revealed a significant difference in the method of delivery 
between the weight loss groups. Vaginal deliveries accounted for a greater 
proportion of the infants in the <7% weight loss group, while caesarian deliveries 
(both scheduled and emergent) accounted for a larger proportion of the infants 
losing ~7% of body weight. During vaginal births there are less medical 
interventions, specifically epidural or spinal anesthesias, which result in an 
increased volume of intravenous therapy being infused at the time of the birth. In 
our study, 75.9% of those in the <7% body weight loss group had an epidural, 
compared with 93.5% of those in the ~7%. This finding was significant, and is 
important to note since the administration of anesthesia concurrently with 
intravenous therapy is a combination that poses a significant risk for excess body 
weight loss, and therefore should be closely monitored. However, it must be 
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acknowledged that specific conditions, which may have led to the decision to use 
a particular delivery method, may also impact weight loss. 
5.3 Limitations 
A number of limitations should be recognized in this study. First, the results of 
this study lack external validity in that the study was conducted in a tertiary 
hospital-based facility, and therefore, was limited to a restricted number of 
practitioners, it is difficult to generalize the results beyond the environment in 
which the data were collected. 
Second, while hospitals and practitioners follow specific clinical practice 
guidelines with regards to procedures, variations can exist between practitioners' 
data collection methods. Considering this study was undertaken some time 
following the infant births, no measure of quality control of patient hospital file 
information was possible. This is always an unavoidable systematic error in 
research that involves secondary data analysis of information not directly 
collected for study purposes. 
Finally, a sizable number of deliveries by midwives were lost due to same 
day discharges and a lack of follow-up assessment of infant body weights. As a 
result, data from births involving midwives are not well represented in this 
sample. Although it is unknown how this limitation might have influenced the 
study results, it is a limitation that must be acknowledged, especially considering 
that the method of delivery was a significant predictor of newborn weight loss. 
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5.4 Conclusions 
In the context of this study, the following conclusions were drawn: 
1. Prevalence of weight loss was significantly higher in our study than that found 
in European studies. This result indicates that future research should be 
undertaken to identify differences between protocols in Europe and North 
America which may account for these variances. 
2. A significant relationship exists between the volume of intravenous therapy 
infused, the method of delivery, and weight loss in the newborn. This 
information is significant in that the infusion of intravenous therapy at the time 
of delivery is a controllable action. Therefore, policies should be reviewed 
regarding the use of intravenous therapy, taking into account the issues of the 
potential significant impacts for the mother, the baby, and the hospital. 
3. An infusion of ~1225ml of normal saline intravenous therapy during the 
intrapartum period increases the potential for the infant to lose ~7% of its birth 
weight regardless of the duration of the infusion. 
4. Infants who lost ~7% of their birth weight weighed 3.6-8.6% more than those 
who lost ::;7% of body weight following birth. The heavier infants also received 
on average 673 ml more intravenous therapy than infants who lost ::;7% of 
their birth weight. 
5. Deliveries by caesarean section, both planned and emergent, accounted for a 
larger number of infants in the ~7% weight loss group. This result is 
consistent with the evidence in the literature. However, since the evidence 
also indicates the number of elective caesarean sections is steadily 
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increasing, attention needs to be paid to this result since this method of 
delivery poses a significantly increased risk for the infant to lost excessive 
weight. 
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CHAPTER 6 - RECOMMENDATIONS FOR FUTURE RESEARCH 
Based on this study, the following are recommendations for future research. 
1. The significant difference in the percentage weight loss in newborns in North 
America and Europe needs to be explored to ascertain if the disparity is due 
to variations in protocol and/or procedures. 
2. A prospective study examining sodium levels pre-, intra- and post-partum in 
the mother, and post-birth in the infant may lend to a further understanding of 
the fluid and electrolyte balance's role in weight loss in the newborn and the 
incidence of hypernatremia. 
3. Further studies examining the benefits and risks of administering a reduced 
volume of intravenous therapy at the time of epidural initiation should be 
undertaken to determine if anesthetic protocols can be safely adjusted. 
4. A larger scale, multi-site study should be undertaken to add external validity 
to this study. This study should include capturing pertinent data from 
community midwife deliveries. 
5. A cost comparison study on delivery and intrapartum interventions, including 
but not limited to intravenous therapy, epidural anesthesia, supplementation, 
and length of hospital stay, should be undertaken to determine the potential 
for cost savings based of a change in policy regarding excess weight loss. 
6. Studies examining the practice of elective caesarean delivery need to be 
completed in order to determine the additional risks to the mother and the 
infant, as well as the additional costs borne by the hospital from this method 
of delivery. 
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APPENDIX 1 - Data Collection Tool 
Client Data 
Date of Birth: _________ _ 
G ____ T ____ P ____ A ____ L ___ _ 
Medical History: 
Gestational Diabetes 
PIH 
peas 
Maternal weight: 
Yes 
Yes 
Yes 
No 
No 
No 
Maternal Weight gain during pregnancy: 
Height: ___ _ BMllstature: ___ _ 
Blood type: ___ _ Rh status: _____ Rhogam: ___ _ 
Fertility treatment Yes No 
If yes, details: 
Meds: 
Other medical conditions: 
Attending: OB/GYN Midwife 
Lab values (list) 
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Labour 
Total Hours: 
Hours in Hospital: ____ _ 
Membrane rupture: Spontaneous Assisted 
Induction: Yes No 
If Yes, Type: ___ _ Amount: Time: 
----- ------
Method of Delivery: 
Vaginal Assisted Vaginal Urgent C-section Planned C-section 
If Assisted Vaginal: Forceps Vacuum 
Epidural: Yes No 
Duration: Amount: 
-------
Analgesia: Yes No 
Type: _______ __ Amount: 
Fever: Yes No 
Onset: Duration: Meds: 
--------
IV Therapy 
IV therapy Yes No 
Type: ____________________ __ 
Rate: 
Total Volume Infused: 
-----------------
Over total time: 
-------------------
Method: Gravity Pump 
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Infant data 
Gender: Male Female 
Gestation (weeks) ____________ _ 
Birthweight: ______________ _ 
Subsequent weights: 
Date Time Age Weight Difference % Loss 
APGAR at birth: 
at 5 minutes: 
Fever: Yes No 
Details: 
Multiple (twin, triplet etc) Yes No 
Hypoglycemia Yes No 
Lab values: 
Value/Date/time: 
Hyperglycemia Yes No 
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Lab values: 
Value/Date/time: 
Hyperbillirubinemia Yes 
Lab values: 
Value/Date/time: 
Hyponatremia Yes 
Lab values: 
Value/Date/time: 
Hypernatremia Yes 
Lab values: 
Value/Date/time: 
Meconium at birth Yes 
Other Medical conditions, medications: 
Infant Feeding Method (choose ONE only) 
Exclusive Breastfeeding (includes EBM) 
Was a Breastfeeding assessment completed? 
No 
No 
No 
No 
Yes 
Yes 
No 
No 
Ifyes,when: ____________________________________________________ ___ 
Time of first feed (within hours of birth): 
Frequency of feeds (q?h): _________ _ 
Amount of feeds: 
----------------------------
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Problems with feed (list): 
Breast and Formula Yes No 
Time of first feed (within hours of birth): 
Frequency of feeds (q?h): _________ _ 
Amount of feeds: 
-------------
Problems with feed (list): 
Formula Only Yes No 
Time of first feed (within hours of birth): 
Frequency of feeds (q?h): 
Amount of feeds: 
-------------
Problems with feed (list): 
Special dietary considerations (i.e. Lactose, GERD) 
Yes No 
List: 
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Appendix 2 - McMaster University REB Letter of Approval 
Date: September 23, 2008 
To: Kim Sheehan 
RN, Stonechurch Family Health Centre 
From: Mary Bedek 
Chief Privacy Officer, HHS 
Re: Research Ethics Board Application 08-444-C Final Approval 
Dear Kim Sheehan: 
The above application for retrospective chart review has been reviewed by the REB 
Chair and the Chief Privacy Officer and has received Final Approval. 
If you require a listing of chart identifiers for this project please contact the Decision 
Support Services Department who will be able to assist you with this data extraction. 
Once you have the chart identifiers please submit the listing to the appropriate health 
records department and to the attention of the individuals listed below. Your records will 
be retrieved within 72 hours. Please note that a maximum of 20 records will be retrieved 
at a time, this is due to space limitations. As well, the records may not be removed from 
the Health Records Department. 
If you require any type of computer assistance, including passwords please contact our 
ICT department. 
Health Records Contacts for Research: 
Site Health Records 
HGH Elsie Soares 
MUMC Gillian Reader 
Henderson Linda Pati 
Chedoke Gillian Reader 
Juravinski Cancer Centre Linda Pati 
At any time if you require assistance from Health Records with your research activities 
please contact one of the management staff listed above or the Manager of Health 
Records and Admitting, Trish Ladouecuer. 
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Appendix 3 - Brock University REB Letter of Approval 
DATE: 
FROM: 
TO: 
FILE: 
TITLE: 
December 12, 2008 
Michelle McGinn, Chair 
Research Ethics Board (REB) 
Dr. M. Plyley, Research and Graduate Studies 
Kim Sheehan 
08-182 PL YLEY/SHEEHAN 
Masters Thesis/Project 
The relationship between intrapartum intravenous therapy 
and newborn weight loss 
The Brock University Research Ethics Board has reviewed the above research proposal. 
DECISION: ACCEPTED AS IS 
This project has received ethics clearance for the period of December 12,2008 to June 30, 
2009 subject to full REB ratification at the Research Ethics Board's next scheduled meeting. 
The clearance period may be extended upon request. The study may now proceed. 
Please note that the Research Ethics Board (REB) requires that you adhere to the protocol 
as last reviewed and cleared by the REB. During the course of research no deviations from, 
or changes to, the protocol, recruitment, or consent form may be initiated without prior written 
clearance from the REB. The Board must provide clearance for any modifications before 
they can be implemented. If you wish to modify your research project, please refer to 
http://www.brocku.calresearchservices/forms to complete the appropriate form Revision or 
Modification to an Ongoing Application. 
Adverse or unexpected events must be reported to the REB as soon as possible with an 
indication of how these events affect, in the view of the Principal Investigator, the safety of the 
participants and the continuation of the protocol. 
If research participants are in the care of a health facility, at a school, or other institution or 
community organization, it is the responsibility of the Principal Investigator to ensure that the 
ethical guidelines and clearance of those facilities or institutions are obtained and filed with 
the REB prior to the initiation of any research protocols. 
The Tri-Council Policy Statement requires that ongoing research be monitored. A Final 
Report is required for aI/ projects upon completion of the project. Researchers with projects 
lasting more than one year are required to submit a Continuing Review Report annually. The 
Office of Research Services will contact you when this form Continuing Review/Final Report 
is required. 
Please quote your REB file number on all future correspondence. 
MM/an 
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Appendix 4 - ROC Curve Analysis of Intravenous Therapy 
Coordinates of the Curve 
Test Result Variable(s): Infusion volume (in millilitres) 
Positive if Greater 
Than or Equal Toa Sensitivity 1 - Specificity 
-1.00 1.000 1.000 
200.00 .957 .833 
450.00 .957 .815 
600.00 .957 .796 
850.00 .957 .778 
1050.00 .957 .704 
1150.00 .935 .667 
1225.00 .913 .667 
1275.00 .848 .648 
1333.50 .826 .630 
1383.50 .804 .630 
1425.00 .783 .611 
1475.00 .783 .593 
1550.00 .783 .556 
1650.00 .717 .556 
1728.50 .696 .519 
1759.50 .696 .500 
1781.00 .696 .481 
1825.00 .674 .481 
1875.00 .674 .463 
1925.00 .674 .444 
1975.00 .674 .426 
2050.00 .543 .370 
2125.00 .522 .370 
2160.50 .500 .315 
2185.50 .478 .315 
2225.00 .457 .315 
2251.00 .391 .278 
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2276.00 .391 .259 
2350.00 .370 .241 
2475.00 .370 .204 
2575.00 .326 .204 
2675.00 .304 .204 
2775.00 .304 .185 
2900.00 .304 .167 
3025.00 .283 .167 
3064.50 .283 .130 
3114.50 .283 .111 
3175.00 .261 .111 
3225.00 .261 .093 
3425.00 .217 .074 
3700.00 .217 .056 
3823.50 .196 .056 
3873.50 .174 .056 
3950.00 .152 .056 
4125.00 .065 .056 
4435.50 .065 .037 
4710.50 .043 .037 
4900.00 .022 .037 
5400.00 .022 .000 
5801.00 .000 .000 
The test result variable(s): Infusion volume in millilitres has at least 
one tie between the positive actual state group and the negative 
actual state group. 
a. The smallest cut-off value is the minimum observed test value 
minus 1, and the largest cut-off value is the maximum observed test 
value plus 1. All the other cut-off values are the averages of two 
consecutive ordered observed test values. 
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